Autologous stem cell transplantation for AL amyloidosis: a standard therapy?
Autologous stem cell transplantation (ASCT) is a new treatment option in patients with systemic AL amyloidosis (AL). The purpose of this review is to summarize the clinical experience of ASCT for AL, and to discuss the feasibility and the future developments of this new approach.
Moreau
P
P
Department of Hematology, CHU Hôtel-Dieu, Place Alexis Ricordeau, 44093 Nantes cedex 01, France.
D000686:Amyloidosis / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous